Form 8.3: SPI LN

Summary by AI BETAClose X

Syquant Capital disclosed a 2.09% derivative position in Spire Healthcare, comprising 8,443,363 1p ordinary shares after dealings on 6 November 2026; it increased its long CFD exposure by 1,236,363 reference shares at prices of c.247–248p (weighted average ≈247.5p). The exposure is held via CFDs (derivatives) rather than direct equity or options, with no subscription rights, indemnities or other arrangements reported and no Supplemental Form 8 attached. The size and recent increase in economic long exposure represents meaningful buy-side interest that could exert upward pressure on Spire's share price, although the derivative structure limits immediate voting influence.

Disclaimer*

UK 100

Latest directors dealings